Support Platform for Type 1 Diabetes

Recruiting at 3 trial locations

Overseen By amelie Roy-Fleming, MSc

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: McGill University

Disqualifiers: Unable to use platform

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 3

322 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if an online training and support platform can improve how adults manage their type 1 diabetes (T1D). Participants will use the platform either as part of their usual medical care or independently alongside their regular care. The goal is to understand if the platform aids self-management and what factors influence its ease of use in real-world settings. Individuals with T1D who live in Canada, have internet access, and can understand English or French may be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative diabetes management solutions.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on using an online platform for diabetes management, so you likely won't need to change your medication routine.

What prior data suggests that this online training and support platform is safe for adults with type 1 diabetes?

Research has shown that the Support platform is generally easy for people to use. In an initial study, participants reported high satisfaction after using the platform for six months, suggesting it is simple and comfortable.

The platform is designed to help people with type 1 diabetes manage their condition more effectively. It offers online training and peer support, accessible whenever needed. No reports of serious side effects have emerged from using the platform, likely because it is a digital tool providing information and support, rather than a medication or medical procedure.

Overall, the Support platform appears safe for users, aiding in diabetes management without causing harm. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about the Support platform for Type 1 Diabetes because it integrates digital tools directly into a patient's regular diabetes care, potentially enhancing the support they receive. Unlike standard treatments that may rely heavily on in-person consultations and manual data tracking, this platform offers a more seamless, tech-driven approach that can be accessed either as part of routine care or independently. This flexibility allows for tailored support, adapting to each patient's needs and potentially improving their self-management and engagement. By leveraging technology, this platform could provide real-time feedback and a more personalized experience, which is a significant step forward from conventional methods.

What evidence suggests that this support platform is effective for type 1 diabetes self-management?

Research has shown that the Support platform can help people with type 1 diabetes manage their condition more effectively. In earlier studies, users of the platform improved their blood sugar control, particularly by lowering their HbA1c levels, an important measure of long-term blood sugar. In this trial, participants will be divided into two groups: one group will integrate the Support platform into their usual care, while the other group will access the platform independently from their regular care. The platform offers online training and support from others with diabetes, which has been linked to increased confidence in managing the condition. It also helps individuals feel more prepared to handle their diabetes as they transition from youth to adulthood. Overall, this online tool is designed to make managing diabetes easier and more effective by providing self-guided learning and connections with peers. ^{1 2 3 6 7}

Who Is on the Research Team?

Anne-Sophie Brazeau, PhD

Principal Investigator

School of human nutrition - McGill University

Are You a Good Fit for This Trial?

This trial is for adults in Canada with Type 1 Diabetes, including latent autoimmune diabetes. Participants must have internet access, an active email address, and understand English or French.

Inclusion Criteria

You are a Canadian resident.

I have been diagnosed with Type 1 diabetes or LADA.

You have access to the web.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete baseline online questionnaires and receive access to the Support platform

1 week

1 visit (virtual)

Intervention

Participants use the Support platform for diabetes self-management, with access either integrated into usual care or independently

12 months

Ongoing virtual engagement

Follow-up

Participants complete follow-up online questionnaires and share glucose data at 6 and 12 months

12 months

2 visits (virtual)

What Are the Treatments Tested in This Trial?

Interventions

• Support platform

Trial Overview The study tests if an online support platform improves self-management of Type 1 Diabetes. One group uses the platform through their clinic; another accesses it independently. They'll use it for a year and share data with researchers.

How Is the Trial Designed?

Group I: Support integrated in usual care Experimental Treatment 1 Intervention

PWT1D participants will have access to Support as part of their regular care (their HCPs will use Support in their care). PWT1D participants in ARM 1 are followed in one of the 4 participating clinics either in-person or remotely or hybrid.

Group II: Support through independent access Active Control 1 Intervention

PWT1D participants will have access to Support, independently from their regular care (they may initiate discussion about the platform with their diabetes care team who might register themselves on the platform, but will not prompt to any specific section on the platform and will not receive any training about the platform). PWT1D participants in ARM 2 can be followed in any other clinics in Canada.

Who Is Running the Clinical Trial?

McGill University

Lead Sponsor

Trials

421

Recruited

1,017,000+

Institut de Recherches Cliniques de Montreal

Collaborator

Trials

72

Recruited

10,300+

Centre de médecine métabolique de Lanaudière

Collaborator

Trials

1

Recruited

320+

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborator

Trials

389

Recruited

143,000+

Centre Hospitalier de l'Universite Laval (CHUL)

Collaborator

Trials

3

Recruited

780+

Centre Hospitalier de l'Université Laval

Collaborator

Trials

2

Recruited

400+

Citations

1. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC12506138/

Support-t, an online training and peer support platform to ... Our primary outcome is haemoglobin A1c (HbA1c) at 18 months (effectiveness outcome). Secondary outcomes include change in self-efficacy for ...

2. pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov/41057177/

Support-t, an online training and peer support platform to ... Secondary outcomes include self-efficacy for diabetes self-management, transition readiness, diabetes-specific quality of life, diabetes ...

3. diabetesjournals.org diabetesjournals.org/care/article/47/8/e54/156793/The-Support-Pro-Online-Training-Platform

The Support-Pro Online Training Platform: Increasing Health ... The online bilingual (English and French) Support platform aims to facilitate diabetes self-management through self-guided education with regular updates.

4. researchgate.net researchgate.net/publication/396278364_Support-t_an_online_training_and_peer_support_platform_to_accompany_youth_living_with_type_1_diabetes_transitioning_to_adult_healthcare_protocol_of_an_effectiveness-implementation_trial

protocol of an effectiveness-implementation trial Support-t , an online training and peer support platform to accompany youth living with type 1 diabetes transitioning to adult healthcare: ...

5. sciencedirect.com sciencedirect.com/science/article/pii/S1751991823001626

How online peer support affects management efficacy and ... Peer-support groups on social media platforms can serve as sources of the necessary information, support, and feedback on diabetes management competence.

6. diabetesjournals.org diabetesjournals.org/diabetes/article/70/Supplement_1/451-P/140011/451-P-Participants-Satisfaction-with-the-Support

451-P: Participants' Satisfaction with the Support Online Self ... This proof-of-concept study aims to evaluate the satisfaction of adults with T1D using the SUPPORT platform after 6 months.

7. journals.plos.org journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0000861

Findings from a pilot clinical trial | PLOS Digital Health In short, this digital platform shows real potential to improve the way families and healthcare teams manage type 1 diabetes together. It could lead to more ...